Concepedia

David S. Moura

DS

22

Publications

922

Citations

15

H-Index

2010

Active since

Affiliations

Hospital Universitario Virgen del Rocío(Current)

Hospital Universitario Son Espases

Instituto de Biomedicina de Sevilla

Hospital Universitario Miguel Servet

Universidad de Sevilla

David S. Moura is an author at Hospital Universitario Virgen del Rocío specializing in medicine, pathology, and oncology.

ORCID

Top concepts

Publications per year

2010–2024

22

Publications

22

Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial

Javier Martín‐Broto, Nadia Hindi, Giovanni Grignani et al. · Journal for ImmunoTherapy of Cancer · 2020 · 169 citations · Full text

Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Silvia Stacchiotti, Antonio López–Pousa et al. · The Lancet Oncology · 2018 · 131 citations

, , +5

VRK1 chromatin kinase phosphorylates H2AX and is required for foci formation induced by DNA damage

Marcella Salzano, Marta Sanz-García, Diana M. Monsalve et al. · Epigenetics · 2015 · 96 citations · Full text

, , +22

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel et al. · The Lancet Oncology · 2020 · 84 citations

, , +5

VRK1 and AURKB form a complex that cross inhibit their kinase activity and the phosphorylation of histone H3 in the progression of mitosis

David S. Moura, Ignacio Campillo‐Marcos, Marta Vázquez-Cedeira et al. · Cellular and Molecular Life Sciences · 2018 · 76 citations · Full text

Rows per page

1–5 of 22